Laura Sichlinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Sichlinger has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Deepak Prakash Srivastava
King's College London
4 shared publications - Anthony Christopher Vernon
Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
3 shared publications - Pooja Raval
King's College London
3 shared publications - Rodrigo R. R. Duarte
Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
2 shared publications - Timothy R. Powell
Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
2 shared publications A. Aabdien
King's College London, Institute of Psychiatry- Psychology & Neuroscience- Department of Basic & Clinical Neuroscience, London, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 22 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (21) , eaea0755
Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons
ZNF804A was among the first genes robustly associated with schizophrenia based on findings from large-scale genomic studies. Previous research has implicated ZNF804A in the regulation of gene expression and synaptic function, but the role of this gene in neurodevelopment and in schizophrenia pathogenesis remains unclear. To study its function during neurodevelopment, we generated isogenic human induced pluripotent stem cells with reduced ZNF804A expression, differentiated them into developing cortical glutamatergic neurons, and studied their transcriptomic, synaptic, and protein signatures. Mutant neurons showed modest evidence for changes in gene expression. However, high-content confocal imaging revealed increased excitatory synapse density in mutant neurons. Cell compartment–specific proteomic analysis further revealed that mutant neurons had higher levels of ribosomal and translational proteins within neurites, and high-content imaging confirmed increased local protein synthesis efficiency. Overall, these results demonstrate that in human developing cortical glutamatergic neurons, ZNF804A regulates excitatory synapse formation potential via increased local protein translation.
- 22 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (21) , eaea0755
Open AccessSchizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons
ZNF804A was among the first genes robustly associated with schizophrenia based on findings from large-scale genomic studies. Previous research has implicated ZNF804A in the regulation of gene expression and synaptic function, but the role of this gene in neurodevelopment and in schizophrenia pathogenesis remains unclear. To study its function during neurodevelopment, we generated isogenic human induced pluripotent stem cells with reduced ZNF804A expression, differentiated them into developing cortical glutamatergic neurons, and studied their transcriptomic, synaptic, and protein signatures. Mutant neurons showed modest evidence for changes in gene expression. However, high-content confocal imaging revealed increased excitatory synapse density in mutant neurons. Cell compartment–specific proteomic analysis further revealed that mutant neurons had higher levels of ribosomal and translational proteins within neurites, and high-content imaging confirmed increased local protein synthesis efficiency. Overall, these results demonstrate that in human developing cortical glutamatergic neurons, ZNF804A regulates excitatory synapse formation potential via increased local protein translation.
- Open Access
CRISPR-mediated transcriptional activation as a mutation-independent therapeutic strategy for SYNGAP1 -related intellectual disability
Synaptic Ras GTPase-activating protein (SynGAP) regulates synaptic strength and neuronal signaling, with essential roles in cortical development and synaptic plasticity. Heterozygous loss-of-function variants in SYNGAP1 cause SYNGAP1 -related intellectual disability (SRID), a severe neurodevelopmental disorder characterized by epilepsy, developmental delay, and autism. SYNGAP1 mutations often result in haploinsufficiency, providing a strong rationale for gene-targeted therapies. However, no treatment currently addresses the underlying genetic cause of SRID. Here, we developed a CRISPR-mediated transcriptional activation (CRISPRa) approach to upregulate the functional Syngap1 allele in a SRID mouse model. CRISPRa activated Syngap1 , normalized SynGAP protein expression and downstream signaling, and rescued working memory deficits. We validated the translational potential of this strategy in human induced pluripotent stem cell (hiPSC)-derived excitatory cortical neurons. CRISPRa rescued SYNGAP1 in two distinct loss-of-function variant lines. Together, these findings demonstrate the feasibility of mutation-independent transcriptional activation as a therapeutic approach for SRID and its broader applicability to haploinsufficiency disorders.
Open AccessCRISPR-mediated transcriptional activation as a mutation-independent therapeutic strategy for SYNGAP1 -related intellectual disability
Synaptic Ras GTPase-activating protein (SynGAP) regulates synaptic strength and neuronal signaling, with essential roles in cortical development and synaptic plasticity. Heterozygous loss-of-function variants in SYNGAP1 cause SYNGAP1 -related intellectual disability (SRID), a severe neurodevelopmental disorder characterized by epilepsy, developmental delay, and autism. SYNGAP1 mutations often result in haploinsufficiency, providing a strong rationale for gene-targeted therapies. However, no treatment currently addresses the underlying genetic cause of SRID. Here, we developed a CRISPR-mediated transcriptional activation (CRISPRa) approach to upregulate the functional Syngap1 allele in a SRID mouse model. CRISPRa activated Syngap1 , normalized SynGAP protein expression and downstream signaling, and rescued working memory deficits. We validated the translational potential of this strategy in human induced pluripotent stem cell (hiPSC)-derived excitatory cortical neurons. CRISPRa rescued SYNGAP1 in two distinct loss-of-function variant lines. Together, these findings demonstrate the feasibility of mutation-independent transcriptional activation as a therapeutic approach for SRID and its broader applicability to haploinsufficiency disorders.
- Open Access
Estradiol regulates local synthesis of synaptic proteome via sex-specific mechanisms
Estrogens, specifically 17β-estradiol (estradiol), can modulate synaptic function by regulating the expression and localisation of synaptic proteins. However, the mechanisms underlying estradiol’s regulation of synaptic protein expression, and whether if they occur in a sex specific manner, is not well understood. In this study, using sex-specific hippocampal slice cultures and mixed-sex primary hippocampal neurons, we investigated whether local protein synthesis is required for estradiol- induced synaptic protein expression. Estradiol rapidly increased the rate of protein synthesis and the number of actively translating ribosomes along dendrites and near synapses in both male and female hippocampal neurons. Importantly, these effects occurred independently of gene transcription. Moreover, estradiol also increased the abundance of nascent proteins localised to synapses, independently of gene transcription. Specifically, estradiol increased the synaptic expression of GluN2B- containing N -methyl-D-aspartate receptors and PSD-95 in male and female hippocampus. Mechanistically, mTOR signalling was required for estradiol-induced increases in overall local protein synthesis only in male but not female hippocampus. Consistent with this, mTOR signalling mediated estradiol increases in GluN2B in male, but not female, hippocampus. Conversely, mTOR inhibition, blocked estradiol-induced increased PSD-95 expression in both male and female hippocampus. Collectively, these data suggest that the rapid modulation of local protein synthesis by estradiol is required for changes in the synaptic proteome in male and female hippocampus, and that the requirement of the mTOR signalling pathway in these effects occur in both a sex-specific and protein-dependent manner, with this signalling pathway have a greater role in male compared to female hippocampus.
Open AccessEstradiol regulates local synthesis of synaptic proteome via sex-specific mechanisms
Estrogens, specifically 17β-estradiol (estradiol), can modulate synaptic function by regulating the expression and localisation of synaptic proteins. However, the mechanisms underlying estradiol’s regulation of synaptic protein expression, and whether if they occur in a sex specific manner, is not well understood. In this study, using sex-specific hippocampal slice cultures and mixed-sex primary hippocampal neurons, we investigated whether local protein synthesis is required for estradiol- induced synaptic protein expression. Estradiol rapidly increased the rate of protein synthesis and the number of actively translating ribosomes along dendrites and near synapses in both male and female hippocampal neurons. Importantly, these effects occurred independently of gene transcription. Moreover, estradiol also increased the abundance of nascent proteins localised to synapses, independently of gene transcription. Specifically, estradiol increased the synaptic expression of GluN2B- containing N -methyl-D-aspartate receptors and PSD-95 in male and female hippocampus. Mechanistically, mTOR signalling was required for estradiol-induced increases in overall local protein synthesis only in male but not female hippocampus. Consistent with this, mTOR signalling mediated estradiol increases in GluN2B in male, but not female, hippocampus. Conversely, mTOR inhibition, blocked estradiol-induced increased PSD-95 expression in both male and female hippocampus. Collectively, these data suggest that the rapid modulation of local protein synthesis by estradiol is required for changes in the synaptic proteome in male and female hippocampus, and that the requirement of the mTOR signalling pathway in these effects occur in both a sex-specific and protein-dependent manner, with this signalling pathway have a greater role in male compared to female hippocampus.
- 1 December 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 53, S115
P.0158 Psychosis risk candidate ZNF804A - a key player in synaptic functioning by regulating local protein synthesis?
- 1 December 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 53, S115
P.0158 Psychosis risk candidate ZNF804A - a key player in synaptic functioning by regulating local protein synthesis?
- 27 September 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 51, e188-e189
W84. PSYCHOSIS RISK CANDIDATE ZNF804A - A KEY PLAYER IN SYNAPTIC FUNCTIONING BY REGULATING LOCAL PROTEIN SYNTHESIS?
- 27 September 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 51, e188-e189
W84. PSYCHOSIS RISK CANDIDATE ZNF804A - A KEY PLAYER IN SYNAPTIC FUNCTIONING BY REGULATING LOCAL PROTEIN SYNTHESIS?
- 1 March 2019
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 145 (3_Suppleme) , 1798
Conversational turn-taking in youth at clinical high-risk for psychosis
Previous studies of speech abnormalities in schizophrenia reflect a consensus that atypical turn-taking behavior during conversation is a prominent feature of speech patterns in psychosis. However, the literature focuses on the population with formal psychosis and lacks studies that involve individuals who are at clinical high-risk (CHR) for developing a psychotic disorder. This study assessed the turn-taking performance of CHR youth to evaluate if abnormalities in turn-taking can be observed in the CHR population compared with controls and to investigate if turn-taking performance is correlated with symptom severity. While analysis of speech data from structured clinical interviews shows no significant group effects, high scores in attenuated psychosis symptoms were associated with significantly longer between turn pauses in the CHR population. This study adds to a growing body of literature that suggests that patterns of speech and linguistic features may be useful in detecting risk, and tracking clinical and treatment course across schizophrenia and spectrum disorders.
- 1 March 2019
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 145 (3_Suppleme) , 1798
Conversational turn-taking in youth at clinical high-risk for psychosis
Previous studies of speech abnormalities in schizophrenia reflect a consensus that atypical turn-taking behavior during conversation is a prominent feature of speech patterns in psychosis. However, the literature focuses on the population with formal psychosis and lacks studies that involve individuals who are at clinical high-risk (CHR) for developing a psychotic disorder. This study assessed the turn-taking performance of CHR youth to evaluate if abnormalities in turn-taking can be observed in the CHR population compared with controls and to investigate if turn-taking performance is correlated with symptom severity. While analysis of speech data from structured clinical interviews shows no significant group effects, high scores in attenuated psychosis symptoms were associated with significantly longer between turn pauses in the CHR population. This study adds to a growing body of literature that suggests that patterns of speech and linguistic features may be useful in detecting risk, and tracking clinical and treatment course across schizophrenia and spectrum disorders.